MedTrace Logo

Validity of Radical 7 Masimo Monitor at Measuring Hemoglobin in Pediatric Cardiac Intensive Care

NCT03977142 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2019-06-06

No results posted yet for this study

Summary

Fifty percent of children that survive a critical illness are anemic at discharge from the pediatric intensive care unit (PICU)(1). Given that there are approximately 9000 PICU admissions/year in Canada, this represents almost 4500 children per year. Anemia is associated with abnormal neurocognitive development in infants and young children. A contributor to PICU anemia is the excessive amount of blood testing and iatrogenic blood losses(2). Non-invasive continuous hemoglobin monitoring (Sp-Hb) have been developed in the medical setting in an attempt to minimize invasive blood testing and reduce blood losses. The Radical 7 Masimo device (Masimo corporation, Irvine, CA) is one of the popular devices used for non-invasive hemoglobin monitoring. Its accuracy has been previously investigated in various populations(3-6). The objective of this study is to investigate the validity of the Radical 7 Masimo device at measuring hemoglobin trends non-invasively in critically ill children.

Conditions

  • Evaluate the Accuracy of the Masimo Radical 7 Hemoglobin Noninvasive Monitor

Interventions

DIAGNOSTIC_TEST

Radical 7 Masimo Hemoglobin pulse co-oximeter non invasive monitor

Measure hemoglobin levels non invasively by pulse co-oximeter

Sponsors & Collaborators

  • St. Justine's Hospital

    lead OTHER

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-31
Primary Completion
2020-01-31
Completion
2020-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03977142 on ClinicalTrials.gov